Most peptides for children sold online, such as BPC-157 or growth hormone “secretagogues,” have never been tested in kids. A small group of peptide drugs is FDA-approved for young people, each for a specific diagnosis: growth hormone for growth hormone deficiency, semaglutide (12 and older) and liraglutide (12 and older) for obesity, and liraglutide, dulaglutide and tirzepatide (10 and older) for type 2 diabetes.[1][2][4][7][8][9]
Children are not small adults. Their bones, hormones and brains are still developing, so a drug tested only in adults can behave differently in a child. This guide lists what is approved, what the trials showed and why everything else should be avoided outside a clinical trial. For background, see our peptide basics hub.
Evidence-graded table
| Peptide or drug | Evidence level | What was shown | FDA status (pediatric) | Our profile |
|---|---|---|---|---|
| Growth hormone (somatropin) | FDA-approved for this use | Improves growth in specific conditions | GHD, Turner, Prader-Willi, SGA, idiopathic short stature[1] | Growth hormone |
| Semaglutide (Wegovy) | FDA-approved for this use | BMI down 16.1% vs up 0.6% on placebo[3] | Obesity, age 12+[2] | Semaglutide |
| Liraglutide (Saxenda, Victoza) | FDA-approved for this use | 43% vs 19% reached 5% BMI drop in teens[5] | Obesity 12+ (over 60 kg); type 2 diabetes 10+[4][7] | Liraglutide |
| Dulaglutide (Trulicity) | FDA-approved for this use | Lowers blood sugar | Type 2 diabetes, age 10+[8] | Dulaglutide |
| Tirzepatide (Mounjaro) | FDA-approved for this use | Lowers blood sugar | Type 2 diabetes, age 10+[9] | Tirzepatide |
| Leuprolide, triptorelin | FDA-approved for this use | Pause early puberty | Central precocious puberty[10][11] | Not available |
| Setmelanotide (Imcivree) | FDA-approved for this use | Weight reduction in rare genetic obesity | Age 2+ (genetic), 4+ (hypothalamic)[12] | Not available |
| Vosoritide (Voxzogo) | FDA-approved for this use | Faster yearly growth | Achondroplasia with open growth plates[13] | Not available |
| Oxytocin (nasal, autism) | Human RCTs (negative) | No better than placebo for social function[15] | Not approved for autism | Oxytocin |
| MK-677 | No pediatric approval | Not approved for anyone | Not approved; FDA safety-risk list[16] | MK-677 |
| BPC-157, TB-500 | No evidence in children | Never studied in children | Not approved | BPC-157 |
Approved peptides for children, by condition
Growth disorders. Growth hormone (somatropin) is a 191-amino-acid protein hormone made by recombinant technology. It is approved for children with growth failure from growth hormone deficiency and several other conditions, including Turner syndrome and Prader-Willi syndrome.[1] Vosoritide, a lab-made version of a natural growth-plate peptide called C-type natriuretic peptide, is approved to increase growth in children with achondroplasia whose growth plates are still open. That approval is accelerated, based on growth speed, with confirmation trials ongoing.[13]
Obesity. The American Academy of Pediatrics’ 2023 guideline says pediatricians should offer adolescents 12 and older with obesity weight-loss medication alongside intensive lifestyle treatment.[14]
- Semaglutide (Wegovy) is approved from age 12.[2] In STEP TEENS, BMI fell 16.1% on semaglutide versus a 0.6% rise on placebo over 68 weeks, and 73% lost at least 5% of their weight.[3]
- Liraglutide (Saxenda) is approved from age 12 for teens over 60 kg.[4] In its teen trial, 43% reached at least a 5% drop in BMI versus 19% on placebo.[5] A 2025 trial in children aged 6 to 11 found BMI fell 5.8% on liraglutide versus a 1.6% rise on placebo, but the US label still starts at 12.[6][4]
- Setmelanotide (Imcivree) treats rare genetic forms of obesity from age 2 and acquired hypothalamic obesity from age 4.[12]
Type 2 diabetes. Liraglutide (Victoza), dulaglutide (Trulicity) and tirzepatide (Mounjaro) are approved for children 10 and older with type 2 diabetes.[7][8][9] Insulin, the original peptide drug, remains essential for type 1 diabetes.
Early puberty. Leuprolide and triptorelin, both synthetic versions of the brain peptide GnRH, are approved to pause central precocious puberty; triptorelin is approved from age 2.[10][11]
Side effects in children mirror those in adults: the GLP-1 drugs commonly cause nausea, vomiting and diarrhea, and all carry warnings that families should review with the prescriber.[2]
Why other peptides are a bad idea for kids
- No pediatric data. BPC-157, TB-500, CJC-1295, ipamorelin and similar products have not been tested in children. Even in adults, the evidence is mostly animal studies.
- Hormones and growth plates. Peptides that raise growth hormone or sex hormones can affect growth and puberty timing in ways only a specialist can monitor.
- Quality. Research peptides are not made to drug standards. Our guide are peptides safe? summarizes contamination studies.
- Sport. Teen athletes who use growth hormone peptides, BPC-157 or similar products can fail drug tests; WADA bans them.[17]
- Safety lists. FDA lists MK-677 among compounding substances that may present significant safety risks.[16]
Teens, social media and online peptides
Teenagers see peptides promoted on social media for muscle, height, tanning and “looksmaxxing.” Products sold as research chemicals can be bought online without a prescription, even though they are not approved for human use. Talk with your teen openly and without judgment about what they’ve seen, and ask directly whether they’ve bought anything.
A few warning signs are worth knowing: vials, syringes or small packages arriving in the mail, injection marks, rapid changes in appetite or weight, or new interest in drug-testing rules for their sport. If you find products, keep the packaging and bring it to your child’s doctor. For student athletes, a positive test can mean suspension; WADA’s list covers growth hormone releasing peptides and many other peptides.[17]
When no approved option fits
For rare conditions, a pediatric specialist may suggest a clinical trial. Trials have consent rules designed to protect children, independent safety monitoring and a defined plan for follow-up, none of which apply to buying a peptide online. Ask your child’s specialist whether a trial is appropriate and how to evaluate it.
Promising ideas that didn’t pan out
Oxytocin nasal spray was widely hoped to improve social skills in autism. In a 24-week trial of 290 children and teens, oxytocin did no better than placebo.[15] It’s a reminder of why claims need testing in children specifically.
Questions to ask your child’s doctor
- Is there an FDA-approved treatment for my child’s condition and age?
- What are the side effects, and how will we monitor growth and development?
- Is my child eligible for a clinical trial, if no approved option fits?
- How should we handle a teen who is buying supplements or peptides online?
Our guides on peptide side effects, talking to your doctor about peptides and the FDA-approved peptides list can help with those conversations.
